[Federal Register Volume 78, Number 164 (Friday, August 23, 2013)]
[Notices]
[Page 52579]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-20622]
-----------------------------------------------------------------------
NUCLEAR REGULATORY COMMISSION
[Docket No. 50-608; NRC-2013-0053]
SHINE Medical Technologies, Inc.
AGENCY: Nuclear Regulatory Commission.
ACTION: Notice of receipt and availability.
-----------------------------------------------------------------------
SUMMARY: The U.S. Nuclear Regulatory Commission (NRC) staff
acknowledges receipt of the second and final part of a two-part
application for a construction permit, submitted by SHINE Medical
Technologies, Inc. (SHINE).
ADDRESSES: Please refer to Docket ID NRC-2013-0053 when contacting the
NRC about the availability of information regarding this document. You
may access publicly-available information related to this action by the
following methods:
Federal Rulemaking Web site: Go to http://www.regulations.gov and search for Docket ID NRC-2013-0053. Address
questions about NRC dockets to Carol Gallagher; telephone: 301-287-
3422; email: [email protected]. For technical questions, contact
the individual(s) listed in the FOR FURTHER INFORMATION CONTACT section
of this document.
NRC's Agencywide Documents Access and Management System
(ADAMS): You may access publicly available documents online in the NRC
Library at http://www.nrc.gov/reading-rm/adams.html. To begin the
search, select ``ADAMS Public Documents'' and then select ``Begin Web-
based ADAMS Search.'' For problems with ADAMS, please contact the NRC's
Public Document Room (PDR) reference staff at 1-800-397-4209, 301-415-
4737, or by email to [email protected]. The ADAMS accession number
for each document referenced in this document (if that document is
available in ADAMS) is provided the first time that the document is
referenced. The application is available in ADAMS under Accession No.
ML13172A324.
NRC's PDR: You may examine and purchase copies of public
documents at the NRC's PDR, Room O1-F21, One White Flint North, 11555
Rockville Pike, Rockville, Maryland 20852.
FOR FURTHER INFORMATION CONTACT: Steven Lynch, Office of Nuclear
Reactor Regulation, U.S. Nuclear Regulatory Commission, Washington, DC,
20555-0001; telephone: 301-415-1524; email: [email protected].
SUPPLEMENTARY INFORMATION: By letter dated May 31, 2013, SHINE filed
with the NRC, pursuant to Section 103 of the Atomic Energy Act and part
50 of Title 10 of the Code of Federal Regulations (10 CFR), the second
and final portion of a two-part application for a construction permit
for a medical radioisotope production facility in Janesville, Wisconsin
(SMT-2013-023, ADAMS Accession No. ML13172A361).
An exemption from certain requirements of 10 CFR 2.101(a)(5),
granted by the Commission on March 20, 2013 (ADAMS Accession No.
ML13072B195), in response to a letter from SHINE dated February 18,
2013 (ADAMS Accession No. ML13051A007), allowed SHINE to submit its
construction permit application in two parts. Specifically, the
exemption allowed SHINE to submit a portion of its application for a
construction permit up to six months prior to the remainder of the
application regardless of whether or not an environmental impact
statement or a supplement to an environmental impact statement is
prepared during the review of its application. SHINE submitted part one
of its construction permit application by letter dated March 26, 2013
(ADAMS Accession No. ML13088A192). A notice of receipt and availability
of part one of the construction permit application was previously
published in the Federal Register on May 20, 2013 (78 FR 29390). The
first part of SHINE's construction permit application contained the
following information:
The description and safety assessment of the site required by
10 CFR 50.34(a)(1)
The environmental report required by 10 CFR 50.30(f)
The filing fee information required by 10 CFR 50.30(e) and 10
CFR 170.21
The general information required by 10 CFR 50.33
The agreement limiting access to classified information
required by 10 CFR 50.37
The NRC staff published in the Federal Register on July 1, 2013 (78
FR 39342), its determination that part one of SHINE's construction
permit application is acceptable for docketing.
Part two of SHINE's application for a construction permit contains
the remainder of the preliminary safety analysis report, as required by
10 CFR 50.34(a).
Subsequent Federal Register notices will address the acceptability
of this second portion of the tendered construction permit application
for docketing and detail provisions for public participation in the
construction permit application review process.
Dated at Rockville, Maryland, this 16th day of August, 2013.
For the Nuclear Regulatory Commission.
Alexander Adams, Jr.,
Chief, Research and Test Reactors Licensing Branch, Division of Policy
and Rulemaking, Office of Nuclear Reactor Regulation.
[FR Doc. 2013-20622 Filed 8-22-13; 8:45 am]
BILLING CODE 7590-01-P